ARTICLE | Clinical News
Regranex becaplermin regulatory update
March 1, 2010 8:00 AM UTC
The CHMP recommended that a contraindication be added to the label for Regranex bercaplermin stating that the dermal ulcers drug must not be used in patients with pre-existing cancer. CHMP is part of...